CERT1 and Alzheimer disease: In the brain tissue of Alz-heimer's disease (AD) patients, levels ofcertain ceramide species are elevated, whilst other sphingolipids like SM are decreased.Ceramide transfer proteins (CERTs) are the only known ceramide carriers, crucial forceramide and SM regulation.